BIOMAT Database Logo BIOMAT Database Logo

Interaction between estrogen receptor alpha, ionizing radiation and (anti-) estrogens in breast cancer cells. 2005

R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Laboratoire Jean-Claude Heuson de Cancérologie Mammaire Institut Jules Bordet, Université Libre de Bruxelles, Bruxelles, Belgium.

OBJECTIVE Estrogen receptor alpha (ERalpha) plays a major role in breast cancer development. It acts as ligand-inducible transcription factor which determines growth, survival and differentiation of breast cancer cells. The aim of this study is to evaluate the potential interference between radiotherapy and estrogen receptor responsiveness. Materials and methods. The effect of ionizing radiation was assessed on the estrogen receptor alpha status, growth (proliferation and apoptosis) and sensitivity of MCF-7 breast cancer cells to estrogenic (17beta-estradiol (E2)), selective estrogen receptor modulator (SERM) and anti-estrogenic compounds. Results. We have observed a ligand-independent decrease in ERalpha expression after radiation, resulting from a specific reduction in mRNA level and protein synthesis. This ERalpha disappearance occurred 72 h post-irradiation at 8 Gy and decreased the transcriptional activity in ERalpha of these cells. On the other hand, E2 impedes the growth inhibitory effects (essentially on proliferation) of ionizing radiation in MCF-7 cells, which potentially decreases radiosensitivity of these cells. This effect was totally blocked by SERM and anti-estrogenic treatments. Moreover, this growth effect of concurrent anti-estrogenic drugs and ionizing radiation appeared to be strongly synergistic. CONCLUSIONS This study may increase general comprehension of ERalpha modulation by radiotherapy and improve adjuvant therapeutic approaches based on co-administration of radiation and endocrine therapy.

UI MeSH Term Description Entries
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D004965 Estrogen Antagonists Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. Estradiol Antagonists,Antagonists, Estradiol,Antagonists, Estrogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer.
January 2010, Genes & development,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer.
November 2008, Current cancer drug targets,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Interaction between ionizing radiation, estrogens and antiestrogens in the modification of tumor microenvironment in estrogen dependent multicellular spheroids.
January 1995, Acta oncologica (Stockholm, Sweden),
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Silencing estrogen receptor alpha in breast cancer cells.
July 2006, Cancer biology & therapy,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Interaction between ionizing radiation and estrogen: what we are missing?
December 2011, Medical hypotheses,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer Cells.
July 2020, Molecular pharmacology,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Estrogen Receptor Alpha and its Ubiquitination in Breast Cancer Cells.
January 2019, Current drug targets,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells.
January 2009, Oncology reports,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer.
January 2008, Anticancer research,
R A Toillon, and N Magné, and I Laïos, and M Lacroix, and H Duvillier, and L Lagneaux, and D Devriendt, and P Van Houtte, and G Leclercq
SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells.
June 2014, Nucleic acids research,
Copied contents to your clipboard!